The FDA approved the first pill for postpartum depression (PPD), a depressive episode that usually happens after women give birth. The drug is called Zurzuvae and it was given fast track approval after only two studies that were not clinical trials. The first few rounds of clinical trials were suspended after they did not go well and the maker of the drug, Sage Pharmaceuticals, said that it would try other ways to earn FDA approval. The FDA says that Zurzuvae can “cause suicidal thoughts and behavior and may cause fetal harm.” So you won’t feel so depressed but you may want to kill yourself. Um…what? ✅ Sign up for our Free DAILY newsletter, delivered right to your inbox first thing in the morning. ➜ ✅ Become a Redacted Rebel VIP and get access to EXCLUSIVE content, live streams, and more! ➜ 👕 REDACTED MERCH 👕 Go grab some Redacted Merch from our store. Go to and pic
Hide player controls
Hide resume playing